UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 03/2020, Volume 323, Issue 18, pp. 1769 - 1770
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Pandemics | Humans | Hypertension - drug therapy | Peptidyl-Dipeptidase A - drug effects | Virus Internalization | COVID-19 | Lung Injury - enzymology | SARS-CoV-2 | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Coronavirus Infections - epidemiology | Pneumonia, Viral - epidemiology | Pneumonia, Viral - complications | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Peptidyl-Dipeptidase A - metabolism | Betacoronavirus | Coronavirus Infections - complications | Lung Injury - drug therapy | Vasodilation - physiology | Antihypertensive Agents - therapeutic use | SARS Virus - pathogenicity | Antihypertensive Agents - adverse effects | Angiotensin-Converting Enzyme 2 | Animals | Hypertension - complications | Mice | Angiotensin Receptor Antagonists - therapeutic use | Angiotensin Receptor Antagonists - adverse effects | Hypertension | Pharmacology, Experimental | Comorbidity | Patient outcomes | Angiotensin II receptor blockers | Specialties and specialists | Practice | Research | Standards | Medicine | Physiology, Pathological | Complications and side effects | Physiological aspects | ACE inhibitors | Angiotensin-converting enzyme inhibitors | Enzymes | Receptors | Enzyme inhibitors | Inhibitors | Converting | Peptidyl-dipeptidase A | Angiotensin | Diuretics | Coronaviruses | Index Medicus | Abridged Index Medicus
Journal Article
Hypertension (Dallas, Tex. 1979), ISSN 0194-911X, 06/2012, Volume 59, Issue 6, pp. 1132 - 1138
Home blood pressure | Pulse wave velocity | Day-by-day home blood pressure variability | Angiotensin II receptor blocker | Thiazide diuretic | Calcium channel blocker | Peripheral Vascular Disease | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiovascular system | Cardiology. Vascular system | Arterial hypertension. Arterial hypotension | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Blood and lymphatic vessels | Antihypertensive agents | Multivariate Analysis | Prospective Studies | Drug Administration Schedule | Follow-Up Studies | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Middle Aged | Calcium Channel Blockers - therapeutic use | Hypertension - drug therapy | Male | Treatment Outcome | Azetidinecarboxylic Acid - analogs & derivatives | Hypertension - physiopathology | Dihydropyridines - therapeutic use | Azetidinecarboxylic Acid - therapeutic use | Diuretics - therapeutic use | Female | Tetrazoles - therapeutic use | Aged | Blood Pressure - drug effects | Blood Pressure Monitoring, Ambulatory - methods | Imidazoles - therapeutic use | Drug Therapy, Combination | Hydrochlorothiazide - therapeutic use | Index Medicus
Journal Article
The American heart journal, ISSN 0002-8703, 2007, Volume 154, Issue 4, pp. 624 - 631
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiology. Vascular system | Biological and medical sciences | Medical sciences | Atenolol - therapeutic use | Marfan Syndrome - drug therapy | Outcome Assessment (Health Care) | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Losartan - therapeutic use | Adult | Marfan Syndrome - complications | Research Design | Adrenergic beta-Antagonists - therapeutic use | Index Medicus | Abridged Index Medicus
Journal Article
Hypertension (Dallas, Tex. 1979), ISSN 0194-911X, 06/2020, Volume 75, Issue 6, pp. 1382 - 1385
COVID-19 | coronavirus | angiotensin receptor blocker | ACE inhibitor | severe acute respiratory syndrome | Pandemics | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Coronavirus Infections - drug therapy | Humans | Pneumonia, Viral - drug therapy | Coronavirus Infections - physiopathology | Peptidyl-Dipeptidase A - physiology | Renin-Angiotensin System - physiology | Angiotensin II Type 1 Receptor Blockers - pharmacology | Pneumonia, Viral - physiopathology | Receptors, Virus - physiology | Pneumonia, Viral - metabolism | Animals | Coronavirus Infections - metabolism | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Betacoronavirus | Renin-Angiotensin System - drug effects | Angiotensin-Converting Enzyme Inhibitors - pharmacology | Receptors, Virus - antagonists & inhibitors | Index Medicus | Reviews | 10010 | 10111
Journal Article
Hypertension (Dallas, Tex. 1979), ISSN 0194-911X, 07/2020, Volume 76, Issue 1, pp. 51 - 58
COVID-19 | coronavirus | angiotensin-converting enzyme inhibitors | angiotensin receptor blocker | inflammation | hypertension | Peripheral Vascular Disease | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Pandemics | Humans | Middle Aged | Medication Therapy Management - statistics & numerical data | Hypertension - drug therapy | Male | Procalcitonin - analysis | Hypertension - blood | SARS-CoV-2 | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Coronavirus Infections - epidemiology | Pneumonia, Viral - epidemiology | Peptidyl-Dipeptidase A - metabolism | Female | Retrospective Studies | Hypertension - epidemiology | C-Reactive Protein - analysis | Betacoronavirus - isolation & purification | Comorbidity | Pneumonia, Viral - therapy | Treatment Outcome | China - epidemiology | Coronavirus Infections - immunology | Pneumonia, Viral - immunology | Angiotensin-Converting Enzyme 2 | Coronavirus Infections - therapy | Hypertension - virology | Survival Analysis | Aged | Angiotensin Receptor Antagonists - therapeutic use | Virus diseases | Hypertension | Care and treatment | Patient outcomes | Severe acute respiratory syndrome | Angiotensin | Antihypertensive drugs | Epidemiology | ACE inhibitors | Index Medicus
Journal Article
Hypertension (Dallas, Tex. 1979), ISSN 0194-911X, 04/2015, Volume 65, Issue 4, pp. 729 - 735
ambulatory blood pressure monitoring | control rate | hypertension | amlodipine | azilsartan | Peripheral Vascular Disease | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Japan - epidemiology | Oxadiazoles - administration & dosage | Administration, Oral | Humans | Middle Aged | Hypertension - drug therapy | Male | Treatment Outcome | Sleep - drug effects | Hypertension - physiopathology | Incidence | Dose-Response Relationship, Drug | Benzimidazoles - administration & dosage | Calcium Channel Blockers - administration & dosage | Female | Aged | Blood Pressure - drug effects | Blood Pressure - physiology | Hypertension - epidemiology | Blood Pressure Monitoring, Ambulatory | Amlodipine - administration & dosage | Angiotensin II Type 1 Receptor Blockers - administration & dosage | Index Medicus
Journal Article
Pharmacological research, ISSN 1043-6618, 06/2020, Volume 156, pp. 104832 - 104832
COVID-19 | ACE2 | SARS-CoV-2 | Coronavirus | Angiotensin receptor blockers | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Hypertension | Coronavirus Infections | Pandemics | Angiotensin Receptor Antagonists | Humans | Betacoronavirus | Pneumonia, Viral | Peptidyl-Dipeptidase A | Diabetes Mellitus | Index Medicus
Journal Article
Nephrology, dialysis, transplantation, ISSN 0931-0509, 09/2006, Volume 21, Issue 9, pp. 2507 - 2512
Brain natriuretic peptide | Cardiovascular disease | Angiotensin receptor antagonists | Randomized trail | Congestive heart failure | Cardiovascular mortality | Transplantation | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Diabetes. Impaired glucose tolerance | Emergency and intensive care: renal failure. Dialysis management | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy | Nephropathies. Renovascular diseases. Renal failure | Renal failure | Nephrology. Urinary tract diseases | Biological and medical sciences | Endocrinopathies | Intensive care medicine | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Associated diseases and complications | Cardiovascular Diseases - etiology | Japan - epidemiology | Prospective Studies | Follow-Up Studies | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Proportional Hazards Models | Male | Survival Rate | Treatment Outcome | Incidence | Kidney Failure, Chronic - therapy | Renal Dialysis - adverse effects | Cardiovascular Diseases - epidemiology | Female | Tetrazoles - therapeutic use | Benzimidazoles - therapeutic use | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 377, Issue 9767, pp. 741 - 750
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Neurology | Biological and medical sciences | General aspects | Vascular diseases and vascular malformations of the nervous system | Medical sciences | Meta-Analysis as Topic | Angiotensin II Type 1 Receptor Blockers - adverse effects | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Hypertension - drug therapy | Male | Stroke - physiopathology | Benzimidazoles - administration & dosage | Tetrazoles - administration & dosage | Treatment Failure | Aged, 80 and over | Female | Blood Pressure - drug effects | Benzimidazoles - adverse effects | Odds Ratio | Angiotensin II Type 1 Receptor Blockers - administration & dosage | Brain Ischemia - complications | Double-Blind Method | Drug Administration Schedule | Europe | Stroke - drug therapy | Hypertension - physiopathology | Antihypertensive Agents - adverse effects | Regression Analysis | Stroke - etiology | Aged | Tetrazoles - adverse effects | Cerebral Hemorrhage - complications | Hypertension | Stroke (Disease) | Complications and side effects | Candesartan | Research | Drug therapy | Health aspects | Studies | Stroke | Blood pressure | Clinical medicine | Index Medicus | Abridged Index Medicus | blood pressure | Hospitals | stroke | Mortality | myocardial infarction | composite materials | Medicin och hälsovetenskap
Journal Article
Hypertension (Dallas, Tex. 1979), ISSN 0194-911X, 07/2020, Volume 76, Issue 1, pp. 16 - 22
Peripheral Vascular Disease | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Pandemics | Comorbidity | Humans | Angiotensin Receptor Antagonists - pharmacology | Hypertension - drug therapy | Renin-Angiotensin System - physiology | Hypertension - metabolism | COVID-19 | Pneumonia, Viral - metabolism | Angiotensin-Converting Enzyme 2 | SARS-CoV-2 | Coronavirus Infections - metabolism | Coronavirus Infections - epidemiology | Coronavirus Infections - virology | Pneumonia, Viral - epidemiology | Betacoronavirus - physiology | Peptidyl-Dipeptidase A - metabolism | Renin-Angiotensin System - drug effects | Angiotensin-Converting Enzyme Inhibitors - pharmacology | Hypertension - epidemiology | Child | Pneumonia, Viral - virology | Hypertension | Pediatrics | Medical colleges | Angiotensin | Kidney diseases | Children | Coronaviruses | Epidemiology | ACE inhibitors | Risk factors | Diseases | Cardiovascular agents | Index Medicus
Journal Article
Circulation research, ISSN 0009-7330, 06/2020, Volume 126, Issue 12, pp. 1671 - 1681
Cardiac & Cardiovascular Systems | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Pandemics | Hospital Mortality | Humans | Middle Aged | Hypertension - drug therapy | Male | Inpatients - statistics & numerical data | COVID-19 | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Coronavirus Infections - epidemiology | Pneumonia, Viral - epidemiology | Pneumonia, Viral - complications | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Coronavirus Infections - complications | Hypertension - complications | Female | Aged | Hypertension - epidemiology | Angiotensin Receptor Antagonists - therapeutic use | Angiotensin Receptor Antagonists - adverse effects | Hypertension | Medical research | Patient outcomes | Analysis | Mortality | Angiotensin | Medicine, Experimental | Antihypertensive drugs | Coronaviruses | ACE inhibitors | Index Medicus | inpatients | Original Research | angiotensin-converting enzyme inhibitor | angiotensin II receptor blocker | 10010 | coronavirus | hypertension
Journal Article